AGP Picks
View all

Yemen Health Report
Provided by AGP

Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on July 23, 2026

Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026
an hour ago

Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026

Indeterminate GlobeNewswire
HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K
an hour ago

HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K

Indeterminate GlobeNewswire
Vaso Corporation Appoints Shaun McMeans to Board of Directors
an hour ago

Vaso Corporation Appoints Shaun McMeans to Board of Directors

Indeterminate GlobeNewswire
Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026
an hour ago

Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026

Indeterminate GlobeNewswire
CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026
2 hours ago

CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026

Indeterminate GlobeNewswire
VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience
2 hours ago

VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience

Indeterminate GlobeNewswire
Instinct Bio Completes Business Combination with Relativity Acquisition Corp. and Makes Its Nasdaq Debut Under the Ticker “BIOT” on July 24, 2026
2 hours ago

Instinct Bio Completes Business Combination with Relativity Acquisition Corp. and Makes Its Nasdaq Debut Under the Ticker “BIOT” on July 24, 2026

Indeterminate GlobeNewswire
The Joint Corp. to Report 2026 Second Quarter Results on Thursday, August 6 and Host Conference Call and Webcast
2 hours ago

The Joint Corp. to Report 2026 Second Quarter Results on Thursday, August 6 and Host Conference Call and Webcast

Indeterminate GlobeNewswire
Crescent Biopharma Announces Grants of Inducement Awards
2 hours ago

Crescent Biopharma Announces Grants of Inducement Awards

Indeterminate GlobeNewswire
Codexis Announces Proposed Public Offering of Common Stock
2 hours ago

Codexis Announces Proposed Public Offering of Common Stock

Indeterminate GlobeNewswire
Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments
2 hours ago

Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments

Indeterminate GlobeNewswire
Abivax renforce ses capacités commerciales avec des nominations stratégiques à des postes clés
2 hours ago

Abivax renforce ses capacités commerciales avec des nominations stratégiques à des postes clés

Indeterminate GlobeNewswire
Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
2 hours ago

Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026

Indeterminate GlobeNewswire
Weight Watchers Schedules Second Quarter 2026 Earnings Conference Call
2 hours ago

Weight Watchers Schedules Second Quarter 2026 Earnings Conference Call

Indeterminate GlobeNewswire
Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
2 hours ago

Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

Indeterminate GlobeNewswire
Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease
2 hours ago

Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease

Indeterminate GlobeNewswire
Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
2 hours ago

Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026

Indeterminate GlobeNewswire
Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026
2 hours ago

Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026

Indeterminate GlobeNewswire
Heartflow to Report Second Quarter 2026 Financial Results on August 13, 2026
2 hours ago

Heartflow to Report Second Quarter 2026 Financial Results on August 13, 2026

Indeterminate GlobeNewswire
MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026
2 hours ago

MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Yemen Health Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.